Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Kunming Pharmaceutical Corp obtains GMP permit

Monday, 6 Jan 2014 07:00pm EST 

Kunming Pharmaceutical Corp:Says obtained a goods manufacturing practice (GMP) permit from Food and Drug Administration, for its small volume injections, with a valid period until Dec. 22, 2018.